Savara Pharmaceuticals
ID: 5330651Savara Pharmaceuticals focuses on the development of an inhaled antibiotic for autoimmune pulmonary alveolar proteinosis (aPAP).
3
Funding Rounds
$16.3m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Savara Pharmaceuticals has raised a total of $7.73m in funding over 3 rounds.
Key Insights:
- Savara Pharmaceuticals Series B round: $6.9m
- Savara Pharmaceuticals Series A round: $833k
- Savara Pharmaceuticals Series B round March 2013: $8.6m
Industries
Savara Pharmaceuticals is active in the following industries: